Decreased survival among lung cancer patients with co-morbid tuberculosis and diabetes
<p>Abstract</p> <p>Background</p> <p>Comorbid conditions influence the survival of cancer patients. This study evaluated the influence of comorbidity on survival among lung cancer patients.</p> <p>Methods</p> <p>The authors evaluated the medical...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-05-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | http://www.biomedcentral.com/1471-2407/12/174 |
id |
doaj-5f158b153aef49cc8d321042d6c87a0b |
---|---|
record_format |
Article |
spelling |
doaj-5f158b153aef49cc8d321042d6c87a0b2020-11-24T22:02:43ZengBMCBMC Cancer1471-24072012-05-0112117410.1186/1471-2407-12-174Decreased survival among lung cancer patients with co-morbid tuberculosis and diabetesShieh Shwn-HueyProbst Janice CSung Fung-ChangTsai Wen-ChenLi Ya-ShinChen Chih-Yi<p>Abstract</p> <p>Background</p> <p>Comorbid conditions influence the survival of cancer patients. This study evaluated the influence of comorbidity on survival among lung cancer patients.</p> <p>Methods</p> <p>The authors evaluated the medical records of 1111 lung cancer patients of a medical center in Taiwan. Days of survival were calculated for each patient and mortality hazard ratios were estimated for associations with demographic status, comorbidity and cancer stage at diagnosis.</p> <p>Results</p> <p>On average, the survival time was slightly longer among women than among men (838 ± 689 vs. 749 ± 654 days, <it>p</it> = 0.050). Survival days increased with age (from 580 ± 526 [≤ 50 years] to 803 ± 693 [≥ 71 years] days, <it>p</it> = 0.020) and decreased with stage (from 1224 ± 656 [stage I] to 489 ± 536 [stage IV] days, <it>p</it> < 0.001). Younger patients were more likely to be diagnosed with lung cancer at a late stage. Compared with lung cancer patients without tuberculosis, those with tuberculosis had a significantly shorter average survival duration (584 vs. 791 days, <it>p</it> = 0.002) and a higher mortality hazard ratio (1.30, 95% CI: 1.03 - 1.65). A similar trend was observed in lung cancer patients with diabetes.</p> <p>Conclusions</p> <p>Lung cancer patients with comorbid tuberculosis or diabetes are at an elevated risk of mortality. These patients deserve greater attention while undergoing cancer treatment.</p> http://www.biomedcentral.com/1471-2407/12/174Lung cancerComorbidityDiabetesSurvivalTuberculosis |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Shieh Shwn-Huey Probst Janice C Sung Fung-Chang Tsai Wen-Chen Li Ya-Shin Chen Chih-Yi |
spellingShingle |
Shieh Shwn-Huey Probst Janice C Sung Fung-Chang Tsai Wen-Chen Li Ya-Shin Chen Chih-Yi Decreased survival among lung cancer patients with co-morbid tuberculosis and diabetes BMC Cancer Lung cancer Comorbidity Diabetes Survival Tuberculosis |
author_facet |
Shieh Shwn-Huey Probst Janice C Sung Fung-Chang Tsai Wen-Chen Li Ya-Shin Chen Chih-Yi |
author_sort |
Shieh Shwn-Huey |
title |
Decreased survival among lung cancer patients with co-morbid tuberculosis and diabetes |
title_short |
Decreased survival among lung cancer patients with co-morbid tuberculosis and diabetes |
title_full |
Decreased survival among lung cancer patients with co-morbid tuberculosis and diabetes |
title_fullStr |
Decreased survival among lung cancer patients with co-morbid tuberculosis and diabetes |
title_full_unstemmed |
Decreased survival among lung cancer patients with co-morbid tuberculosis and diabetes |
title_sort |
decreased survival among lung cancer patients with co-morbid tuberculosis and diabetes |
publisher |
BMC |
series |
BMC Cancer |
issn |
1471-2407 |
publishDate |
2012-05-01 |
description |
<p>Abstract</p> <p>Background</p> <p>Comorbid conditions influence the survival of cancer patients. This study evaluated the influence of comorbidity on survival among lung cancer patients.</p> <p>Methods</p> <p>The authors evaluated the medical records of 1111 lung cancer patients of a medical center in Taiwan. Days of survival were calculated for each patient and mortality hazard ratios were estimated for associations with demographic status, comorbidity and cancer stage at diagnosis.</p> <p>Results</p> <p>On average, the survival time was slightly longer among women than among men (838 ± 689 vs. 749 ± 654 days, <it>p</it> = 0.050). Survival days increased with age (from 580 ± 526 [≤ 50 years] to 803 ± 693 [≥ 71 years] days, <it>p</it> = 0.020) and decreased with stage (from 1224 ± 656 [stage I] to 489 ± 536 [stage IV] days, <it>p</it> < 0.001). Younger patients were more likely to be diagnosed with lung cancer at a late stage. Compared with lung cancer patients without tuberculosis, those with tuberculosis had a significantly shorter average survival duration (584 vs. 791 days, <it>p</it> = 0.002) and a higher mortality hazard ratio (1.30, 95% CI: 1.03 - 1.65). A similar trend was observed in lung cancer patients with diabetes.</p> <p>Conclusions</p> <p>Lung cancer patients with comorbid tuberculosis or diabetes are at an elevated risk of mortality. These patients deserve greater attention while undergoing cancer treatment.</p> |
topic |
Lung cancer Comorbidity Diabetes Survival Tuberculosis |
url |
http://www.biomedcentral.com/1471-2407/12/174 |
work_keys_str_mv |
AT shiehshwnhuey decreasedsurvivalamonglungcancerpatientswithcomorbidtuberculosisanddiabetes AT probstjanicec decreasedsurvivalamonglungcancerpatientswithcomorbidtuberculosisanddiabetes AT sungfungchang decreasedsurvivalamonglungcancerpatientswithcomorbidtuberculosisanddiabetes AT tsaiwenchen decreasedsurvivalamonglungcancerpatientswithcomorbidtuberculosisanddiabetes AT liyashin decreasedsurvivalamonglungcancerpatientswithcomorbidtuberculosisanddiabetes AT chenchihyi decreasedsurvivalamonglungcancerpatientswithcomorbidtuberculosisanddiabetes |
_version_ |
1725834324117291008 |